search button

CEA AND CA-19.9 AS MARKERS OF COLORECTAL NEOPLASMS DURING CHEMOTHERAPEUTIC TREATMENT

  • Authors:
    • A COMANDONE
    • S BRETTI
    • E AROASIO
    • M RAPELLINO
    • M BUGIANI
    • F COTRONEO
    • C BUMMA

  • View Affiliations

  • Published online on: July 1, 1994     https://doi.org/10.3892/or.1.4.779
  • Pages: 779-782
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Carcinoembryonic antigen and CA 19.9 are markers of colorectal neoplasms, often related to tumor burden. Elevated pre-operative levels parallel disease extent and may foresee adverse prognosis. CEA and CA 19.9 may increase post-operatively, indicating tumor recurrence. Only limited data are available on the influence of chemotherapeutic treatments on these two markers, to detect chemotherapy-induced cytolysis. We measured CEA and CA 19.9 before and after a chemotherapy regimen of five days consisting of folinic acid and 5-fluorouracil in forty patients with colorectal cancer. No consistent fluctuation was detected, the examined tumor markers being related in a given patient only to tumor burden.

Related Articles

Journal Cover

July 1994
Volume 1 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.2
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.4
  • CiteScore Rank: Q1: #68/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.786
  • SCImago Journal Rank (SJR): 0.812
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
COMANDONE A, BRETTI S, AROASIO E, RAPELLINO M, BUGIANI M, COTRONEO F and BUMMA C: CEA AND CA-19.9 AS MARKERS OF COLORECTAL NEOPLASMS DURING CHEMOTHERAPEUTIC TREATMENT. Oncol Rep 1: 779-782, 1994
APA
COMANDONE, A., BRETTI, S., AROASIO, E., RAPELLINO, M., BUGIANI, M., COTRONEO, F., & BUMMA, C. (1994). CEA AND CA-19.9 AS MARKERS OF COLORECTAL NEOPLASMS DURING CHEMOTHERAPEUTIC TREATMENT. Oncology Reports, 1, 779-782. https://doi.org/10.3892/or.1.4.779
MLA
COMANDONE, A., BRETTI, S., AROASIO, E., RAPELLINO, M., BUGIANI, M., COTRONEO, F., BUMMA, C."CEA AND CA-19.9 AS MARKERS OF COLORECTAL NEOPLASMS DURING CHEMOTHERAPEUTIC TREATMENT". Oncology Reports 1.4 (1994): 779-782.
Chicago
COMANDONE, A., BRETTI, S., AROASIO, E., RAPELLINO, M., BUGIANI, M., COTRONEO, F., BUMMA, C."CEA AND CA-19.9 AS MARKERS OF COLORECTAL NEOPLASMS DURING CHEMOTHERAPEUTIC TREATMENT". Oncology Reports 1, no. 4 (1994): 779-782. https://doi.org/10.3892/or.1.4.779